Úlceras corneanas por amebas de vida libre en la Fundación Oftalmológica de Santander. Informe de casos

Vista sencilla de ítem
dc.contributor.authorSerrano Calderón, Carolinaspa
dc.contributor.authorCastillo, Carmen Aliciaspa
dc.contributor.authorGalvis Ramírez, Virgiliospa
dc.contributor.authorGómez, Augusto Joséspa
dc.contributor.authorVillareal Martínez, Donaldospa
dc.contributor.authorSerrano Rey, Juan Joséspa
dc.contributor.cvlacSerrano Rey, Juan José [0000265306]spa
dc.contributor.cvlacGalvis Ramírez, Virgilio [0000552453]spa
dc.contributor.googlescholarSerrano Rey, Juan José [njpNpaUAAAAJ&hl=es&oi=ao]spa
dc.contributor.orcidSerrano Rey, Juan José [0000-0002-6946-2444 ]spa
dc.contributor.researchgateSerrano Calderón, Carolina [Serrano-Calderon-Carolina-35417984]spa
dc.contributor.researchgroupObservatorio de Salud Pública de Santanderspa
dc.contributor.researchgroupGrupo de Investigaciones Clínicasspa
dc.contributor.scopusSerrano Rey, Juan José [54793298100]spa
dc.date.accessioned2020-10-27T14:21:09Z
dc.date.available2020-10-27T14:21:09Z
dc.date.issued2007-08-15
dc.description.abstractResumenLa queratitis por amebas de vida libre ha surgido durante los últimos 30 años, como una de las enfermedades corneanas de más difícil diagnóstico y con menores tasas de curación Su sintomatología típica de dolor ocular severo, sobrestimado para una ulceración corneal pequeña precedida de un antecedente de trauma, contacto con aguas no potables o uso de lentes de contacto debe hacernos sospechar lapresencia de estos microorganismos. Recientemente los tratamientos se han ido haciendo  un poco más efectivos sobre todo cuando la enfermedad es detectada en estadios tempranos y en este aspecto el desarrollo de métodos diagnósticos y el aumento en la sospecha clínica han sido de gran utilidad. Se presenta la descripción de tres casos con características clínicas especiales, su manejo y evoluciónpostratamiento.[Serrano-Calderón C, Castillo CA, Galvis V, Gómez AJ, Villareal D, Rey JJ. Úlceras corneanas por amebas de vida libre en la Fundación Oftalmológica de Santander. Informe de casos. MedUNAB 2007; 10:121-129].spa
dc.description.abstractenglishFree-living amoeba keratitis has emerged over the last 30 years as one of the most difficult to diagnose corneal diseases with the lowest cure rates Its typical symptoms of severe eye pain, overestimated for a small corneal ulceration preceded by a history of trauma, contact with non-potable water or the use of contact lenses should make us suspect the presence of these microorganisms. Recently, treatments have become a little more effective, especially when the disease is detected in early stages, and in this regard, the development of diagnostic methods and the increase in clinical suspicion have been very useful. The description of three cases with special clinical characteristics, their management and post-treatment evolution is presented.eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.identifier.issn2382-4603
dc.identifier.issn0123-7047
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.identifier.urihttp://hdl.handle.net/20.500.12749/10346
dc.language.isospaspa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/113/100
dc.relation.references1. Alizadeh H, Niederkon JY, McCauley JP. Acanthamoebic keratitis. In: Pepose JS, Holand GN, Wilhemus KR (eds). Ocular infection and immunity. St. Louis, Mosby, 1996: 1062-71.spa
dc.relation.references2. Mathers WD, Sutphin JE, Lane JA. Correlation between surface water contamination with amoeba and the onset of symptoms and diagnosis of amoeba-like keratitis. Br J Ophthalmol 1998; 82:1143spa
dc.relation.references3. Illingworth C, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol 1998; 42:493-508spa
dc.relation.references4. Oddo BD. Infections caused by free-living amebas: Historical commentaries, taxonomy and nomenclature, protozoology and clinicopathologic features. Rev Chil Infectol 2006; 23:200-14.spa
dc.relation.references5. Rutzen AR, Moore MB. Parasitic infections. In: Kaufman HE, McDonald MB (eds). The cornea. Butterworth Heinemann, 1998:311.spa
dc.relation.references6. Sun X, Zhang Y, Li R. Acanthamoeba keratitis: Clinical characteristics and management. Ophthalmology 2006; 113:412-6spa
dc.relation.references7. Merayo-Lloves J, Vredeveld CM, Vitale AT. Free-living amebas and amebiasis. In: Foster S, Vitale AT (eds). Diagnosis and treatment of uveitis. Philadelphia, Saunders, 2002: 411-6spa
dc.relation.references8. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 2006, 17:327-31spa
dc.relation.references9. Hammersmith KM.. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 2006; 17:32-5spa
dc.relation.references10. Berger ST, Mondito BJ, Hoft RH. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 1990, 110:395-403spa
dc.relation.references11. D`aversa G, Stern GA, Diebre WT. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 1995, 113:1120-3spa
dc.relation.references12. Hargrave SL, McCulley JP, Husseini Z. Results of a Trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study mol 2006, 124:923. Group. Ophthalmology 1999, 106:9527spa
dc.relation.references13. Kosrirukvongs P, Wanachiwanawin D, Visvesvara GS. molecular epidemiology and new drugs for treatment. Treatment of Acanthamoeba keratitis with Chlorhexi- Eye 2003, 17:893-905. dine. Ophthalmology 1999, 106:798802.spa
dc.relation.references14. Hay S, Kirkness C. Successful medical therapy of Van Klink F, et al. Role of mucosal IgA in the resistance to acanthamoeba keratitis with topical chlorhexidine and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci propamidine. Eye 1997, 10:113-21spa
dc.relation.references15. Varga JH, Wolf TC, Jensen HG. Combined treatment 20. Brooks JG, Coster DJ, Badenoch PR. Acanthamoeba with propamidine, neomycin and polyhexamethylene keratitis. Resolution after epithelial debridement. Cornea biguanide. Am J Ophthalmol 1993; 115:466spa
dc.relation.references16. Ishibashi Y, Matsumoto Y, Kabata T. Oral itraconazole and topical miconazole with debridement for acanthamoeba keratitis. Am J Ophthalmol 1990, 109:121-6.spa
dc.relation.references17. Mathers W. Use of higher medication concentrations in the treatment of Acanthamoeba keratitis. Arch Ophthal 129 mol 2006, 124:923.spa
dc.relation.references18. Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Treatment of Acanthamoeba keratitis with Chlorhexi- Eye 2003, 17:893-905.spa
dc.relation.references19. Leher HF, Alizadeh H, Taylor WM, Shea AS, Silvany RS, 14. Hay S, Kirkness C. Successful medical therapy of Role of mucosal IgA in the resistance to acanthamoeba keratitis with topical chlorhexidine and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci propamidine. Eye 1997, 10:113-21. 1998; 39:2666-73.spa
dc.relation.references20. Brooks JG, Coster DJ, Badenoch PR. Acanthamoeba with propamidine, neomycin and polyhexamethylene keratitis. Resolution after epithelial debridement. Cornea biguanide. Am J Ophthalmol 1993; 115:466. 1994, 13:186-9spa
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/article/view/113
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceMedUNAB; Vol. 10 Núm. 2 (2007): Especial Oftalmología; 121-129
dc.subjectCiencias de la salud
dc.subjectMedicina
dc.subjectCiencias médicas
dc.subjectCiencias biomédicas
dc.subjectCiencias de la vida
dc.subjectInnovaciones en salud
dc.subjectInvestigaciones
dc.subject.keywordsHealth Scienceseng
dc.subject.keywordsMedicineeng
dc.subject.keywordsMedical Scienceseng
dc.subject.keywordsBiomedical Scienceseng
dc.subject.keywordsLife Scienceseng
dc.subject.keywordsInnovations in healtheng
dc.subject.keywordsResearcheng
dc.subject.keywordsCorneal ulcerseng
dc.subject.keywordsAmoebaseng
dc.subject.keywordsEye paineng
dc.subject.proposalÚlceras corneanasspa
dc.subject.proposalAmebasspa
dc.subject.proposalDolor ocularspa
dc.titleÚlceras corneanas por amebas de vida libre en la Fundación Oftalmológica de Santander. Informe de casos
dc.title.translatedCorneal ulcers due to free-living amoebas at the Santander Ophthalmology Foundation. Case reporteng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localArtículospa
dc.type.redcolhttp://purl.org/redcol/resource_type/ART

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
2015_Articulo_Carolina_Serrano.pdf
Tamaño:
283.95 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo
Descargar

Colecciones

Revista MedUNAB
Grupo de Investigaciones Clínicas
Observatorio de Salud Pública de Santander